Please ensure Javascript is enabled for purposes of website accessibility

WellPoint Holds Up Well

By Stephen D. Simpson, Simpson, – Updated Nov 15, 2016 at 6:03PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Going with quality can soften the blow when a sector goes out of favor.

There's no shortage of investable health-plan companies out there, and likewise no shortage of opinion on who is best. Some folks like UnitedHealth (NYSE:UNH), others Coventry (NYSE:CVH), and still others turn their attention to the likes of Sierra (NYSE:SIE) or Health Net (NYSE:HNT). As for me, I've been a fan of WellPoint (NYSE:WLP) for a little while now, and the company's performance seems to be rewarding that position.

This has been a very tough stretch for these managed-care companies, but WellPoint has come through relatively well. And it certainly doesn't hurt that the second quarter's numbers looked reasonably good. Revenue was up about 27% as reported, and up in excess of 10% on a comparable basis (netting out the impact of a large acquisition). Likewise, growth in income was pretty good this quarter.

Turning to enrollment and medical costs, the news isn't quite so positive, though it's still arguably better than what we've now seen from others like Aetna (NYSE:AET). Apart from the acquisition, enrollment grew about 2%, and the company didn't suggest that enrollment growth would subsequently pick up significantly. Once again, it raises a valid question: Have these companies have pushed pricing so high that it will be difficult to continue adding customers?

On the cost side, the reported medical loss ratio was higher than last year (that's bad), but actually down a bit when adjusted for the deal (that's good). Moreover, the company continues to project that medical cost trends will remain below 8%, which seems to be the magic number for analysts and institutional investors these days.

Having liked WellPoint before, I still like it now. I think there's quite a bit of potential here, and though Aetna may be even cheaper, investing there carries a higher level of risk and uncertainty. I'm not suggesting that WellPoint will be able to fully resist industrywide difficulties in pricing, enrollment growth, and/or medical costs if that's the way the wind blows, but I do still believe this is a stock worth some consideration.

For related Foolishness:

Coventry is a Motley Fool Stock Advisor selection. UnitedHealth is both anInside ValueandStock Advisorrecommendation.Take the newsletter that best fits your investing style for a 30-day free spin.

Fool contributor Stephen Simpson has no financial interest in any stocks mentioned (that means he's neither long nor short the shares).

None

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Elevance Health Inc. Stock Quote
Elevance Health Inc.
ELV
$448.14 (-1.26%) $-5.71
Aetna Inc. Stock Quote
Aetna Inc.
AET
UnitedHealth Group Incorporated Stock Quote
UnitedHealth Group Incorporated
UNH
$508.36 (-1.02%) $-5.25
Coventry Health Care Inc. Stock Quote
Coventry Health Care Inc.
CVH

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.